Some promise with respect to preventing senescence-associated changes in RPE and potentially impacting AMD development has been demonstrated experimentally using compounds like resveratrol, which impact the expression and activity of SIRT1, a down-stream NAD+-dependent gene that in turn, governs processes essential to the maintenance of cellular viability [44–46]. Here, SIRT1 is linked to age-related macular degeneration.